Publication | Closed Access

Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence

InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRheumatic DiseasesSubcutaneous Tnf-alpha InhibitorsImmunologyPsoriatic ArthritisAutoimmunityPaediatric RheumatologyInflammatory Rheumatic DiseaseTreatment PersistenceImmunotherapyMedicineRheumatoid ArthritisImmune-mediated Rheumatic Disease